Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome.

Antibiotics Bacterial diversity Bacterial orders Bacterial richness Gut microbiota Recovery from antibiotic treatment Synbiotics

Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 27 02 2019
accepted: 24 06 2019
pubmed: 3 7 2019
medline: 24 6 2021
entrez: 3 7 2019
Statut: ppublish

Résumé

Pro- and synbiotics have been reported to ameliorate the adverse (dysbiotic) effects of antibiotics on the gut microbial architecture, but little is known how synbiotics and antibiotics interact with each other in shaping the gut microbiota. To explore this mutual interaction we examined, first, the effect of a multi-strain synbiotic on antibiotic-induced dysbiosis and, second, the dysbiotic effect of antibiotics followed by prolonged synbiotic exposure. The synbiotic containing nine bacterial strains was administered to male mice via the drinking water, while the antibiotic mix containing bacitracin, meropenem, neomycin, and vancomycin was administered via oral gavage. Two experimental protocols were used. In protocol 1, mice were administered placebo or synbiotic for 3 weeks prior to and during an 11-day vehicle or antibiotic treatment. In protocol 2 the synbiotic was administered for a prolonged period of time, starting 3 weeks prior and continuing for 12 weeks after an 11-day vehicle or antibiotic treatment. Subsequently, the fecal microbiome was analyzed by 16S rRNA sequencing using oligonucleotide primers 16s_515_S3_fwd: GATTGCCAGCAGCCGCGGTAA and 16s_806_S2_rev: GGACTACCAGGGTATCTAAT followed by sequencing using the Ion Torrent One. The final sequence files were analyzed by QIIME 1.8 workflow scripts. Antibiotic treatment markedly decreased the bacterial richness and diversity of the fecal microbiota. Synbiotic administration for 3 weeks prior to and during an 11-day antibiotic treatment preserved the Lactobacillales and expanded the Verrucomicrobiales and Bifidobacteriales order, but did not prevent the depletion of Bacteroidales and the short-term proliferation of Enterobacteriales. When the synbiotic administration was continued for 12 weeks after the end of antibiotic treatment, the rise of Verrucomicrobiales was maintained, whereas the preservation of Lactobacillales and boost of Bifidobacteriales was lost. The abundance of Clostridiales was enhanced by long-term synbiotic treatment after short-term exposure to antibiotics, while the antibiotic-depleted Bacteroidales underwent a delayed recovery. There are complex synergistic and antagonistic interactions of synbiotics and antibiotics in influencing distinct bacterial orders of the fecal microbiota. The impact of a short-term antibiotic exposure is profoundly different when analyzed after synbiotic pretreatment or following prolonged synbiotic administration in the post-antibiotic period.

Identifiants

pubmed: 31263983
doi: 10.1007/s00394-019-02035-z
pii: 10.1007/s00394-019-02035-z
pmc: PMC7351849
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1831-1844

Subventions

Organisme : Österreichische Forschungsförderungsgesellschaft
ID : CBmed
Organisme : Österreichischer Wissenschaftsfonds (FWF)
ID : P25912-B23
Organisme : Österreichischer Wissenschaftsfonds (FWF)
ID : W1241-B18

Références

Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. https://doi.org/10.1038/nature11234
doi: 10.1038/nature11234
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230. https://doi.org/10.1038/nature11550
doi: 10.1038/nature11550 pubmed: 22972295 pmcid: 3577372
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031. https://doi.org/10.1038/nature05414
doi: 10.1038/nature05414 pubmed: 17183312
Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V, Finlay BB (2012) Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12:611–622. https://doi.org/10.1016/j.chom.2012.10.012
doi: 10.1016/j.chom.2012.10.012 pubmed: 23159051
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628. https://doi.org/10.1038/nature25979
doi: 10.1038/nature25979 pubmed: 29555994 pmcid: 6108420
Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E, Segal E (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555:210–215. https://doi.org/10.1038/nature25973
doi: 10.1038/nature25973 pubmed: 29489753
Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, Horn M, Cohen Y, Moor AE, Zeevi D, Korem T, Kotler E, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Pevsner-Fischer M, Shapiro H, Sharon I, Halpern Z, Segal E, Elinav E (2018) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174:1406.e16–1423.e16. https://doi.org/10.1016/j.cell.2018.08.047
doi: 10.1016/j.cell.2018.08.047
Zmora N, Suez J, Elinav E (2019) You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol 16:35–56. https://doi.org/10.1038/s41575-018-0061-2
doi: 10.1038/s41575-018-0061-2 pubmed: 30262901
LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P (2017) Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact 16:79. https://doi.org/10.1186/s12934-017-0691-z
doi: 10.1186/s12934-017-0691-z pubmed: 28482838 pmcid: 5423028
Shortt C, Hasselwander O, Meynier A, Nauta A, Fernández EN, Putz P, Rowland I, Swann J, Türk J, Vermeiren J, Antoine JM (2018) Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur J Nutr 57:25–49. https://doi.org/10.1007/s00394-017-1546-4
doi: 10.1007/s00394-017-1546-4 pubmed: 29086061
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167:915–932. https://doi.org/10.1016/j.cell.2016.10.027
doi: 10.1016/j.cell.2016.10.027 pubmed: 27814521 pmcid: 5127403
Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S (2016) From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry 21:738–748. https://doi.org/10.1038/mp.2016.50
doi: 10.1038/mp.2016.50 pubmed: 27090305 pmcid: 4879184
Dinan TG, Cryan JF (2017) Brain–gut-microbiota axis and mental health. Psychosom Med 79:920–926. https://doi.org/10.1097/PSY.0000000000000519
doi: 10.1097/PSY.0000000000000519 pubmed: 28806201
Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc 6:e004947. https://doi.org/10.1161/JAHA.116.004947
doi: 10.1161/JAHA.116.004947 pubmed: 28663251 pmcid: 5586261
Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14:573–584. https://doi.org/10.1038/nrgastro.2017.88
doi: 10.1038/nrgastro.2017.88 pubmed: 28743984 pmcid: 5880536
Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249. https://doi.org/10.1038/nature11552
doi: 10.1038/nature11552 pubmed: 22972297
Hartstra AV, Bouter KE, Bäckhed F, Nieuwdorp M (2015) Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38:159–165. https://doi.org/10.2337/dc14-0769
doi: 10.2337/dc14-0769 pubmed: 25538312
Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P (2017) Non-alcoholic fatty liver disease: an update with special focus on the role of gut microbiota. Metabolism 71:182–197. https://doi.org/10.1016/j.metabol.2017.03.013
doi: 10.1016/j.metabol.2017.03.013 pubmed: 28521872
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66
doi: 10.1038/nrgastro.2014.66 pubmed: 24912386
Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O (2016) Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 8:52. https://doi.org/10.1186/s13073-016-0300-5
doi: 10.1186/s13073-016-0300-5 pubmed: 27159972 pmcid: 4862129
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14:491–502. https://doi.org/10.1038/nrgastro.2017.75
doi: 10.1038/nrgastro.2017.75 pubmed: 28611480
Di Cerbo A, Palmieri B, Aponte M, Morales-Medina JC, Iannitti T (2016) Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol 69:187–203. https://doi.org/10.1136/jclinpath-2015-202976
doi: 10.1136/jclinpath-2015-202976 pubmed: 26578541
Ottman N, Reunanen J, Meijerink M, Pietilä TE, Kainulainen V, Klievink J, Huuskonen L, Aalvink S, Skurnik M, Boeren S, Satokari R, Mercenier A, Palva A, Smidt H, de Vos WM, Belzer C (2017) Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One 12:e0173004. https://doi.org/10.1371/journal.pone.0173004
doi: 10.1371/journal.pone.0173004 pubmed: 28249045 pmcid: 5332112
Pan F, Zhang L, Li M, Hu Y, Zeng B, Yuan H, Zhao L, Zhang C (2018) Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie-restricted mice. Microbiome 6:54. https://doi.org/10.1186/s40168-018-0440-5
doi: 10.1186/s40168-018-0440-5 pubmed: 29562943 pmcid: 5863386
Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodríguez-Cabezas ME, Gálvez J (2017) Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 61:1–13. https://doi.org/10.1002/mnfr.201700144
doi: 10.1002/mnfr.201700144
Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC (2017) Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis. PLoS One 12:e0171579. https://doi.org/10.1371/journal.pone.0171579
doi: 10.1371/journal.pone.0171579 pubmed: 28182644 pmcid: 5300201
Szajewska H, Kołodziej M, Gieruszczak-Białek D, Skórka A, Ruszczyński M, Shamir R (2019) Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children—a 2019 update. Aliment Pharmacol Ther 49:1376–1384. https://doi.org/10.1111/apt.15267
doi: 10.1111/apt.15267 pubmed: 31025399
Allen SJ, Wareham K, Wang D, Bradley C, Sewell B, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D, Phillips CJ (2013) A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess 17:1–140. https://doi.org/10.3310/hta17570
doi: 10.3310/hta17570 pubmed: 24309198 pmcid: 4781647
Ouwehand AC, DongLian C, Weijian X, Stewart M, Ni J, Stewart T, Miller LE (2014) Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine 32:458–463. https://doi.org/10.1016/j.vaccine.2013.11.053
doi: 10.1016/j.vaccine.2013.11.053 pubmed: 24291194
Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC (2019) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 4:CD004827. https://doi.org/10.1002/14651858.CD004827.pub5
doi: 10.1002/14651858.CD004827.pub5 pubmed: 31039287
McFarland LV, Huang Y, Wang L, Malfertheiner P (2016) Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United Eur Gastroenterol J 4:546–561. https://doi.org/10.1177/2050640615617358
doi: 10.1177/2050640615617358
Blaabjerg S, Artzi DM, Aabenhus R (2017) Probiotics for the prevention of antibiotic-associated diarrhea in outpatients—a systematic review and meta-analysis. Antibiotics (Basel) 6:E21. https://doi.org/10.3390/antibiotics6040021
doi: 10.3390/antibiotics6040021
Bagga D, Aigner CS, Reichert JL, Cecchetto C, Fischmeister FPhS, Holzer P, Moissl-Eichinger C, Schöpf V (2018) Influence of 4-week multi-strain probiotic administration on resting-state functional connectivity in healthy volunteers. Eur J Nutr. https://doi.org/10.1007/s00394-018-1732-z
doi: 10.1007/s00394-018-1732-z pubmed: 29850990 pmcid: 6647073
Moser AM, Spindelboeck W, Halwachs B, Strohmaier H, Kump P, Gorkiewicz G, Högenauer C (2018) Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome. Eur J Nutr. https://doi.org/10.1007/s00394-018-1826-7
doi: 10.1007/s00394-018-1826-7 pubmed: 30251020 pmcid: 6768888
Persborn M, Gerritsen J, Wallon C, Carlsson A, Akkermans LM, Söderholm JD (2013) The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther 38:772–783. https://doi.org/10.1111/apt.12451
doi: 10.1111/apt.12451 pubmed: 23957603
Leblhuber F, Steiner K, Schuetz B, Fuchs D, Gostner JM (2018) Probiotic supplementation in patients with Alzheimer’s dementia—an explorative intervention study. Curr Alzheimer Res 15:1106–1113. https://doi.org/10.2174/1389200219666180813144834
doi: 10.2174/1389200219666180813144834 pubmed: 30101706 pmcid: 6340155
Bagga D, Reichert JL, Koschutnig K, Aigner CS, Holzer P, Koskinen K, Moissl-Eichinger C, Schöpf V (2018) Probiotics drive gut microbiome triggering emotional brain signatures. Gut Microbes 9:486–496. https://doi.org/10.1080/19490976.2018.1460015
doi: 10.1080/19490976.2018.1460015 pubmed: 29723105 pmcid: 6287679
Reininghaus EZ, Wetzmair LC, Fellendorf FT, Platzer M, Queissner R, Birner A, Pilz R, Hamm C, Maget A, Koidl C, Riedrich K, Klampfer K, Ferk K, Dalkner N (2018) The impact of probiotic supplements on cognitive parameters in euthymic individuals with bipolar disorder: a pilot study. Neuropsychobiology 19:1–9. https://doi.org/10.1159/000492537
doi: 10.1159/000492537
Wilms E, Gerritsen J, Smidt H, Besseling-van der Vaart I, Rijkers GT, Garcia Fuentes AR, Masclee AA, Troost FJ (2016) Effects of supplementation of the synbiotic Ecologic
doi: 10.1371/journal.pone.0167775 pubmed: 27936169 pmcid: 5147956
Fröhlich EE, Farzi A, Mayerhofer R, Reichmann F, Jačan A, Wagner B, Zinser E, Bordag N, Magnes C, Fröhlich E, Kashofer K, Gorkiewicz G, Holzer P (2016) Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota–brain communication. Brain Behav Immun 56:140–155. https://doi.org/10.1016/j.bbi.2016.02.020
doi: 10.1016/j.bbi.2016.02.020 pubmed: 26923630 pmcid: 5014122
Schmieder R, Edwards R (2011) Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS One 6:e17288. https://doi.org/10.1371/journal.pone.0017288
doi: 10.1371/journal.pone.0017288 pubmed: 21408061 pmcid: 3052304
Bragg L, Stone G, Imelfort M, Hugenholtz P, Tyson GW (2012) Fast, accurate error-correction of amplicon pyrosequences using Acacia. Nat Methods 9:425–426. https://doi.org/10.1038/nmeth.1990
doi: 10.1038/nmeth.1990 pubmed: 22543370
Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460–2461. https://doi.org/10.1093/bioinformatics/btq461
doi: 10.1093/bioinformatics/btq461 pubmed: 20709691 pmcid: 20709691
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335–336. https://doi.org/10.1038/nmeth.f.303
doi: 10.1038/nmeth.f.303 pubmed: 20383131 pmcid: 20383131
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. https://doi.org/10.1186/gb-2011-12-6-r60
doi: 10.1186/gb-2011-12-6-r60 pubmed: 21702898 pmcid: 21702898
Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB, Federici S, Cohen Y, Linevsky R, Rothschild D, Moor AE, Ben-Moshe S, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Shapiro H, Pevsner-Fischer M, Sharon I, Halpern Z, Segal E, Elinav E (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174:1388.e21–1405.e21. https://doi.org/10.1016/j.cell.2018.08.041
doi: 10.1016/j.cell.2018.08.041
Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, Pamer EG (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Investig 120:4332–4341. https://doi.org/10.1172/JCI43918
doi: 10.1172/JCI43918 pubmed: 21099116
Raymond F, Déraspe M, Boissinot M, Bergeron MG, Corbeil J (2016) Partial recovery of microbiomes after antibiotic treatment. Gut Microbes 7:428–434. https://doi.org/10.1080/19490976.2016.1216747
doi: 10.1080/19490976.2016.1216747 pubmed: 27494088 pmcid: 5154369
Ge X, Ding C, Zhao W, Xu L, Tian H, Gong J, Zhu M, Li J, Li N (2017) Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med 15:13. https://doi.org/10.1186/s12967-016-1105-4
doi: 10.1186/s12967-016-1105-4 pubmed: 28086815 pmcid: 5237163
Crouzet L, Derrien M, Cherbuy C, Plancade S, Foulon M, Chalin B, van Hylckama Vlieg JET, Grompone G, Rigottier-Gois L, Serror P (2018) Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge. Sci Rep 8:5098. https://doi.org/10.1038/s41598-018-23437-9
doi: 10.1038/s41598-018-23437-9 pubmed: 29572473 pmcid: 5865147
Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of enterobacteriaceae. Cell Host Microbe 2:119–129. https://doi.org/10.1016/j.chom.2007.06.010
doi: 10.1016/j.chom.2007.06.010 pubmed: 18005726
Turroni F, Ventura M, Buttó LF, Duranti S, O’Toole PW, Motherway MO, van Sinderen D (2014) Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71:183–203. https://doi.org/10.1007/s00018-013-1318-0
doi: 10.1007/s00018-013-1318-0 pubmed: 23516017
O’Callaghan A, van Sinderen D (2016) Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol 7:925. https://doi.org/10.3389/fmicb.2016.00925
doi: 10.3389/fmicb.2016.00925 pubmed: 27379055 pmcid: 4908950
Drissi F, Raoult D, Merhej V (2017) Metabolic role of lactobacilli in weight modification in humans and animals. Microb Pathog 106:182–194. https://doi.org/10.1016/j.micpath.2016.03.006
doi: 10.1016/j.micpath.2016.03.006 pubmed: 27033001
Shi Y, Zhai Q, Li D, Mao B, Liu X, Zhao J, Zhang H, Chen W (2017) Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model. Microbiol Res 200:14–24. https://doi.org/10.1016/j.micres.2017.04.001
doi: 10.1016/j.micres.2017.04.001 pubmed: 28527760
Heeney DD, Gareau MG, Marco ML (2018) Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol 49:140–147. https://doi.org/10.1016/j.copbio.2017.08.004
doi: 10.1016/j.copbio.2017.08.004 pubmed: 28866243
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110:9066–9071. https://doi.org/10.1073/pnas.1219451110
doi: 10.1073/pnas.1219451110 pubmed: 23671105
Cani PD, de Vos WM (2017) Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol 8:1765. https://doi.org/10.3389/fmicb.2017.01765
doi: 10.3389/fmicb.2017.01765 pubmed: 29018410 pmcid: 5614963
Wu W, Lv L, Shi D, Ye J, Fang D, Guo F, Li Y, He X, Li L (2017) Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front Microbiol 2017(8):1804. https://doi.org/10.3389/fmicb.2017.01804
doi: 10.3389/fmicb.2017.01804
Guida F, Turco F, Iannotta M, De Gregorio D, Palumbo I, Sarnelli G, Furiano A, Napolitano F, Boccella S, Luongo L, Mazzitelli M, Usiello A, De Filippis F, Iannotti FA, Piscitelli F, Ercolini D, de Novellis V, Di Marzo V, Cuomo R, Maione S (2018) Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun 67:230–245. https://doi.org/10.1016/j.bbi.2017.09.001
doi: 10.1016/j.bbi.2017.09.001 pubmed: 28890155
Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A (2017) Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9:E555. https://doi.org/10.3390/nu9060555
doi: 10.3390/nu9060555 pubmed: 28555037
Laurell A, Sjöberg K (2017) Prebiotics and synbiotics in ulcerative colitis. Scand J Gastroenterol 52:477–485. https://doi.org/10.1080/00365521.2016.1263680
doi: 10.1080/00365521.2016.1263680 pubmed: 27931127

Auteurs

Angela Jačan (A)

CBmed GmbH-Center for Biomarker Research in Medicine, Stiftingtalstrasse 5, 8010, Graz, Austria.
Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.

Karl Kashofer (K)

Diagnostic and Research Institute of Pathology, Diagnostic and Research Center of Molecular Biomedicine, Medical University of Graz, Neue Stiftingtalstrasse 6, 8010, Graz, Austria.

Geraldine Zenz (G)

Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.

Esther E Fröhlich (EE)

Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.

Florian Reichmann (F)

Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.

Ahmed M Hassan (AM)

Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria.

Peter Holzer (P)

Research Unit of Translational Neurogastroenterology, Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Universitätsplatz 4, 8010, Graz, Austria. peter.holzer@medunigraz.at.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH